Not Found

The requested URL /jquery-1.6.3.min.js was not found on this server.

Is the EU Considering the Relocation of the London UPC Central Division?

Written by Louise AMAR   // 13 July 2017   // Comments Off

The EU is considering the relocation of the London UPC Central Division.

Could Michel Barnier push for relocation of the UPC Division based in London? 

It is reported that in a meeting about the Brexit negotiations, Michel Barnier, current chief negotiator for the EU, mentioned that Brussels is reviewing whether London can keep its Central Division of the Unified Patent Court after Brexit.

This relocation could be motivated by the fact that the European Medicine Agency (as well as the European Banking Authority), whose mission is to evaluate European medicinal products  will be relocated on the territory of the EU, as indicated by the European Council decision on the “Procedure leading up to a decision on the relocation of the European Medicines Agency and the European Banking Authority“.

As the third UPC central division will be competent for pharmaceuticals, chemistry and metallurgy, this potential relocation seems to indicate that the EU is trying to achieve a coherent EU framework for those industries.

However, if it actually takes place, this relocation will be particularly significant. Indeed, the United Kingdom accounts for 11% of extra-EU exports of medicinal and pharmaceutical products and is thus considered as one of the European leaders in this industry. Furthermore, it should be considered against the fact that the UK is currently taking the final steps towards the ratification of the UPC Agreement and has notified its approval to the Protocol to the Agreement on the Unified Patent Court on provisional application a few days ago. This potential relocation project therefore begs the question of whether it could jeopardise the UK’s participation to the Unitary patent package and its ability to contribute to the UPC case law on issues of particular economic interests for its economy.


Tags:

Brexit

UK


Similar posts

Comments are closed.

Advocate General

AIPPI

Alignment

Article 83

Belgium

Bifurcation

Brexit

Brussels I Regulation

Chronology

Committee

Consultation

Court Fees

Damages

Discussion

Draft Rules of Procedure

e-Filing prototype

Entry into Force

EPO

EU Legislation

EU Regulation 1257/2012

EU Regulation 1260/2012

European Commission

European Parliament

european patent

European Patent Convention

Event

Evidence

Germany

Infringement

Interim Measures

Italy

Key dates

Legal certainty

Legal framework

Licensees

London

Malta Problem

Mediation

Mock Trial

Opt-out

Oral Procedure

Order for inspection

Order to preserve evidence

Patent Attorneys

Patent Cooperation Treaty

patent regime

Patent Trolls

Portugal

Preparatory Committee

Protective Measures

Protocol to the Agreement on a Unified Patent Court

Provisional Application phase

Provisional Measure

Public Consultation

Recoverable Costs

Renewal Fees

Representation

SME

Spain v Council of the EU

Start of Proceedings

Summaries and Guides

Summary

Supplementary Protection Certificate

survey

Training

Transitional period

Translation

UK

UK rat

unitary effect

Unitary Patent

Unitary Patent Protection

United Kingdom

UP overview

UPC

UPC Agreement

UPC Appeals

UPC Austria

UPC Candidate Judges

UPC Case Management System

UPC Code of Conduct

UPC Competence

UPC Conference and Workshops

UPC Denmark

UPC Divisions

UPC Draft Rules Procedure

UPC France

UPC Languages

UPC News

UPC operational

UPC overview

UPC Preparatory Committee

UPC Procedure

UPC Ratification

UPC Sources

UPC Sources of Law

UPC structure

UPC Timetable

Videos

Webinar